PAI Pharma Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • PAI Pharma's estimated annual revenue is currently $54.9M per year.(i)
  • PAI Pharma's estimated revenue per employee is $201,000

Employee Data

  • PAI Pharma has 273 Employees.(i)
  • PAI Pharma grew their employee count by 25% last year.

PAI Pharma's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operating Officer (COO)Reveal Email/Phone
3
Chief Commercial Officer (CCO)Reveal Email/Phone
4
VP OperationsReveal Email/Phone
5
VP - Strategic FinanceReveal Email/Phone
6
VP, Sales – Generic ProductsReveal Email/Phone
7
VP Supply ChainReveal Email/Phone
8
VP Regulatory Affairs and Quality AssuranceReveal Email/Phone
9
VP - BD & PortfolioReveal Email/Phone
10
Director, Analytical R&DReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9M4515%N/AN/A
#2
$1.7M430%$82.4MN/A
#3
$208M1035-3%$799MN/A
#4
$8.4M425%N/AN/A
#5
$11.9M59-3%N/AN/A
#6
$378.3M1882-8%N/AN/A
#7
$75M3734%N/AN/A
#8
$58.9M2937%N/AN/A
#9
$14.3M71-3%N/AN/A
#10
$8.8M44-2%N/AN/A
Add Company

What Is PAI Pharma?

PAI Pharma is the industry leader of high-quality, US-made liquid and unit-dose medications. For over 50 years, PAI Pharma has produced and distributed suspensions, oral solutions, elixirs, syrups, liquids, and semi-solids. To meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies, we offer standard bottle packaging and ready-to-dispense unit-dose cups.\nOur mission is to participate in the creation of healthier lives by exceeding the expectations of those we serve. We do this by being the ultimate partner of choice—consistently, reliably, affordably deliver the medication the patient needs, every time.

keywords:N/A

N/A

Total Funding

273

Number of Employees

$54.9M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M276N/AN/A
#2
$108.3M279-6%N/A
#3
$58.9M2937%N/A
#4
$7.5M300-2%N/A
#5
$103.6M3079%N/A